You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 5,998,581


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,998,581
Title: Reductive alkylation of glycopeptide antibiotics
Abstract:This invention is concerned with improved processes for reductive alkylation of glycopeptide antibiotics. The improvement residing in providing a source of copper which results in the initial production of a copper complex of the glycopeptide antibiotic. Reductive alkylation of this complex favors regioselective alkylation and increased yields. Copper complexes of the glycopeptide antibiotic starting materials and of the alkylated products are also part of the invention.
Inventor(s): Berglund; Richard Alan (Lafayette, IN), Lockwood; Nancy Anne (Mountlake Terrace, WA), Magadanz; Howard Eugene (Lafayette, ID), Zheng; Hua (Lafayette, ID)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:09/290,204
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

United States Patent 5,998,581: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 5,998,581, hereafter referred to as the '581 patent, is a significant intellectual property asset that has contributed to the advancement of its respective field. This article provides a comprehensive analysis of the scope, claims, and the broader patent landscape surrounding this patent.

Background and Invention

To understand the '581 patent, it is crucial to delve into its background and the invention it protects. The patent typically includes a detailed description of the invention, its purpose, and how it differs from prior art.

Claims Analysis

Independent and Dependent Claims

The '581 patent includes a set of claims that define the scope of the invention. These claims are categorized into independent and dependent claims. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide more specific details[3].

Claim Construction

Claim construction is a critical step in understanding the patent's scope. It involves interpreting the language of the claims to determine what is covered by the patent. This process is often subject to legal scrutiny and can be a point of contention in patent litigation[2].

Scope of the Invention

The scope of the '581 patent is defined by its claims and the description provided in the specification. This includes the specific features, components, and methods that are protected by the patent. Understanding the scope is essential for determining infringement and validity.

Patent Landscape

Prior Art and Novelty

The '581 patent must have been novel and non-obvious at the time of its filing. The patent landscape includes an analysis of prior art that was considered during the examination process. This helps in understanding how the '581 patent innovates beyond existing technologies[4].

Related Patents and Patent Families

The patent landscape also includes related patents and patent families. These are patents that are related to the '581 patent either through common inventors, assignees, or subject matter. Tools like the Global Dossier and the Common Citation Document (CCD) can be used to identify these related patents[4].

Inventorship and Ownership

True and Only Inventors

The '581 patent lists the inventors who contributed to the conception and reduction to practice of the invention. Ensuring that the true and only inventors are listed is crucial for the patent's validity and enforceability[2].

Assignment and Ownership Changes

Patent assignments and changes in ownership can affect the rights and obligations associated with the '581 patent. The Patent Assignment Search database can be used to track these changes[4].

Patent Term and Adjustments

Patent Term Adjustment (PTA)

The '581 patent's term may have been adjusted due to delays in the prosecution process. Understanding the adjusted expiration date is crucial for determining the patent's current status and any potential extensions or disclaimers[1].

Terminal Disclaimers

If the '581 patent faced obviousness-type double patenting (ODP) issues, terminal disclaimers might have been filed to overcome these rejections. Terminal disclaimers can affect the patent term and are considered in ODP analyses[1].

Enforcement and Litigation

Infringement and Validity

The '581 patent can be enforced against infringers, but its validity can be challenged. Understanding the claims and scope is essential for both enforcing the patent and defending against validity challenges.

Ex Parte Reexamination

The '581 patent could be subject to ex parte reexamination if new prior art or substantial new questions of patentability arise. This process can lead to the reevaluation of the patent's claims and potentially result in changes to the patent's scope[1].

Economic and Strategic Impact

Market Dominance

The '581 patent can provide its owner with a competitive advantage in the market. By excluding others from practicing the invention, the patent can help in achieving market dominance.

Licensing and Collaboration

The patent can also be used as a bargaining chip for licensing agreements or collaborations. This can expand the reach of the invention and generate revenue through royalties.

Current Status and Expiration

Patent Expiration Date

The '581 patent's expiration date is critical for understanding its current status. Patents typically expire 20 years from the filing date, but adjustments due to PTA or terminal disclaimers can alter this date[1].

Post-Expiration Strategies

After the patent expires, the invention enters the public domain. Companies may need to adapt their strategies to maintain competitiveness, such as through continued innovation or alternative forms of intellectual property protection.

Key Takeaways

  • Claims and Scope: Understanding the independent and dependent claims is crucial for determining the patent's scope.
  • Patent Landscape: Analyzing related patents and prior art helps in understanding the innovation and novelty of the '581 patent.
  • Inventorship and Ownership: Correctly identifying inventors and tracking ownership changes is vital for the patent's validity and enforceability.
  • Patent Term Adjustments: Terminal disclaimers and PTA can affect the patent term and are important for ODP analyses.
  • Enforcement and Litigation: The patent can be enforced against infringers, but its validity can be challenged through ex parte reexamination.

Frequently Asked Questions (FAQs)

1. What is the significance of independent and dependent claims in a patent?

Independent claims define the invention broadly, while dependent claims provide more specific details and build upon the independent claims.

2. How does the Global Dossier help in patent research?

The Global Dossier provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family and related documentation.

3. What is the role of terminal disclaimers in patent law?

Terminal disclaimers are used to overcome obviousness-type double patenting (ODP) rejections and can affect the patent term by ensuring that the later-expiring patent does not extend beyond the earlier-expiring patent.

4. How can the Patent Assignment Search database be useful?

The Patent Assignment Search database helps in tracking changes in patent ownership, which is crucial for understanding the current rights and obligations associated with a patent.

5. What happens to an invention after the patent expires?

After the patent expires, the invention enters the public domain, and anyone can practice the invention without infringing on the former patent.

Cited Sources:

  1. In re Cellect - United States Court of Appeals for the Federal Circuit, 2023.
  2. Determining Inventorship for US Patent Applications - Oregon State University, 2023.
  3. Patent Claims Research Dataset - USPTO, 2017.
  4. Search for patents - USPTO, 2018.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,998,581

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.